Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveVelaris Therapeutics Acquired by Alaunos Therapeutics

Live News MNA FLASH L impact Oct 13, 2026, 11:02 AM UTC

Velaris Therapeutics Acquired by Alaunos Therapeutics

Velaris Therapeutics was acquired by Alaunos Therapeutics, Inc.

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

TCRT

Related stories

Veritas Weighs Sale of Chromalloy for More Than $10 Billion Veritas is reportedly weighing a sale of Chromalloy valued at more than $10 billion, Bloomberg News reports. M impact | MNA | Oct 23, 2026, 07:01 PM UTC Frasers Raises Hugo Boss Stake Above 50%, Making It a Subsidiary Frasers said it raised its stake in Hugo Boss to more than 50%, making the German fashion group a subsidiary of the British retailer. M impact | MNA | Oct 23, 2026, 05:37 PM UTC CVC and GBL Secure 74.3% Stake in Recordati Takeover Offer A regulatory filing showed the investors held 74.3% of Recordati at the end of the offer period. They had raised their bid to €53 per share earlier this month. M impact | MNA | Oct 23, 2026, 05:33 PM UTC Shanghai International Group to Buy 1.24 Billion Haitong Unitrust Shares M impact | MNA | Oct 23, 2026, 05:33 PM UTC Verisk to Proceed With $2.35 Billion AccuLynx Acquisition After Court Order Verisk will proceed with its acquisition of AccuLynx after Delaware’s Supreme Court affirmed a Chancery Court ruling that AccuLynx could not terminate the deal. M impact | MNA | Oct 23, 2026, 05:32 PM UTC South Africa Competition Tribunal Unconditionally Approves Impact Energies Deal M impact | MNA | Oct 23, 2026, 05:28 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.